CF
LLY icon

Centaurus Financial’s Eli Lilly LLY Stock Holding History

Centaurus Financial’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.2M Sell
11,138
-127
-1% -$129K 0.49% 44
2025
Q4 		$12.1M Sell
11,265
-2,072
-16% -$1.98M 0.55% 38
2025
Q3 		$10.2M Buy
13,337
+227
+2% +$169K 0.48% 47
2025
Q2 		$10.2M Sell
13,110
-616
-4% -$479K 0.6% 38
2025
Q1 		$11.3M Sell
13,726
-712
-5% -$592K 0.69% 38
2024
Q4 		$11.1M Buy
14,438
+2,975
+26% +$2.46M 0.68% 35
2024
Q3 		$10.2M Buy
11,463
+5,364
+88% +$4.82M 0.65% 37
2024
Q2 		$5.52M Buy
6,099
+3,085
+102% +$2.47M 0.37% 62
2024
Q1 		$2.35M Buy
3,014
+1,011
+50% +$719K 0.16% 135
2023
Q4 		$1.17M Buy
2,003
+35
+2% +$20.4K 0.09% 218
2023
Q3 		$1.06M Sell
1,968
-685
-26% -$353K 0.09% 221
2023
Q2 		$1.24M Sell
2,653
-1,568
-37% -$658K 0.11% 197
2023
Q1 		$1.45M Sell
4,221
-599
-12% -$202K 0.12% 198
2022
Q4 		$1.76M Buy
4,820
+948
+24% +$336K 0.17% 148
2022
Q3 		$1.25M Buy
3,872
+464
+14% +$147K 0.12% 198
2022
Q2 		$1.1M Buy
3,408
+1,092
+47% +$328K 0.11% 220
2022
Q1 		$663K Sell
2,316
-8
-0.3% -$2.06K 0.05% 354
2021
Q4 		$642K Buy
2,324
+343
+17% +$87K 0.05% 381
2021
Q3 		$458K Buy
+1,981
New +$489K 0.04% 439
2021
Q2 		– Sell
-616
Closed -$115K – 920
2021
Q1 		$115K Buy
+616
New +$120K 0.01% 752
2018
Q3 		– Sell
-6,214
Closed -$530K – 1386
2018
Q2 		$530K Buy
6,214
+3,159
+103% +$259K 0.07% 291
2018
Q1 		$236K Buy
+3,055
New +$246K 0.06% 299

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Centaurus Financial's LLY Position: Q1 2026 in Review

Centaurus Financial reduced its Eli Lilly (LLY) stake by 1.1% in Q1 2026, selling an estimated $129K and leaving 11,138 shares worth $10.2M. The position accounts for 0.49% of the portfolio, ranked #44.

Centaurus Financial first reported a position in LLY in Q1 2018 and has held it in 22 quarters since. The position peaked at $12.1M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Centaurus Financial held 11,138 shares of Eli Lilly worth $10.2M as of Q1 2026.
  • Centaurus Financial sold 127 Eli Lilly shares in Q1 2026, an estimated $129K.
  • Eli Lilly made up 0.49% of Centaurus Financial's portfolio in Q1 2026, its #44 holding.
  • Centaurus Financial first reported a position in Eli Lilly in Q1 2018 and has held it in 22 quarters since.
  • Centaurus Financial's Eli Lilly position peaked at $12.1M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Centaurus Financial's 13F filing for Q1 2026, filed 18 May 2026.